• Loading stock data…

DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Mutant Metastatic Non-Small Cell Lung Cancer

[#item_full_content]

Print Friendly, PDF & Email
Spread the word